Skip to content

Medical emergency? What to do

Most take news of genetic Alzheimer's risk well

3-RXPublished July 16, 20093 min read

Key points

  • Adult children who have a parent with Alzheimer's disease may want to know if they carry a gene that raises their risk of getting the mind-robbing disease.
  • In the REVEAL study, researchers found that disclosing APOE test results to adult children of patients with Alzheimer's disease "did not result in significant short-term psychological risks."
  • In the study, 162 healthy middle-aged adult children who had a parent with Alzheimer's disease were randomly assigned to receive the results of their APOE genetic test (the disclosure group) or not to receive the results (the nondisclosure group).
  • "Subjects were not immune to the negative implications of learning that they had an increased risk, but these feelings were not associated with clinically significant psychological distress," Green and colleagues point out.

Adult children who have a parent with Alzheimer's disease may want to know if they carry a gene that raises their risk of getting the mind-robbing disease. But can they handle the test result, psychologically? Findings from a study released today hint that most can handle the information.

The e4 version of the apolipoprotein E (APOE) gene is associated with an increased risk of Alzheimer's disease, as well as impaired memory in people without dementia and with progression to Alzheimer's disease in people with mild thinking impairment.

In the REVEAL study, researchers found that disclosing APOE test results to adult children of patients with Alzheimer's disease "did not result in significant short-term psychological risks."

Test-related distress was reduced among those learning they did not carry the Alzheimer's-associated gene and was only modestly and transiently increased in those told they did carry the gene, Dr. Robert C. Green of Boston University School of Medicine and colleagues report in Thursday's issue of The New England Journal of Medicine.

In the study, 162 healthy middle-aged adult children who had a parent with Alzheimer's disease were randomly assigned to receive the results of their APOE genetic test (the disclosure group) or not to receive the results (the nondisclosure group).

People who were informed of their test results, the researchers found, did not have significantly more depression or anxiety than those who were not informed of their test results either immediately after receiving the test results or 1 year later. That was true regardless of whether they were in the subgroup of people found to carry the high-risk APOE e4 gene variant.

"Subjects were not immune to the negative implications of learning that they had an increased risk, but these feelings were not associated with clinically significant psychological distress," Green and colleagues point out.

And for those who were told they did not possess the high-risk gene variant, testing provided a benefit, they report.

"I have worked with families with Alzheimer's disease for quite a while and I thought it might be possible to disclose this information without harming them, but the consensus, sort of, was that this would be commonly met with a great deal of psychological distress," Green told Reuters Health.

"As a first step in exploring the impact of disclosure, I think these results are quite interesting," Green added.

The authors of a commentary caution, however, that it's very likely that the people who agreed to participate in this study were "sufficiently indifferent to the potential test results...and thus are not representative of those who have a strong perceived need to know or need not to know."

Moreover, Drs. Rosalie A. and Robert L. Kane, of University of Minnesota, Minneapolis, pose the question: "Could any societal good or harm result from widespread, on-demand genetic testing for APOE e4?"

"Societal benefit seems unlikely," they contend, "given that it is not possible to prevent Alzheimer's disease, and available treatments have at best a modest effect on disease progression."

"Societal harm from testing remains possible," they add, "given that Alzheimer's disease is widely regarded as being singularly horrific."

SOURCE: The New England Journal of Medicine, July 16, 2009.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underBrainNeurology

Keep reading

Neurology

Neurologist Develops New Educational Tool

With a new application developed by a U-M neurologist, better understanding of the anatomy of the peripheral nervous system can be found right on your iPhone. Nerve Whiz is a free application for medical…

2 min read

Brain

A better way to remember

Scientists and educators alike have long known that cramming is not an effective way to remember things. With their latest findings, researchers at the RIKEN Brain Science Institute in Japan, studying eye movement…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.